Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phenotypic Screen with TSC-Deficient Neurons Reveals Heat-Shock Machinery as a Druggable Pathway for mTORC1 and Reduced Cilia. | Cell Rep | 2020 | 32579942 | PubTator, text mining | PubMed |
| mTOR Overcomes Multiple Metabolic Restrictions to Enable HIV-1 Reverse Transcription and Intracellular Transport. | Cell Rep | 2020 | 32579936 | PubTator, text mining | PubMed |
| DEPDC5 haploinsufficiency drives increased mTORC1 signaling and abnormal morphology in human iPSC-derived cortical neurons. | Neurobiol Dis | 2020 | 32574724 | PubTator, text mining | PubMed |
| PI 3-kinase delta enhances axonal PIP3 to support axon regeneration in the adult CNS. | EMBO Mol Med | 2020 | 32558386 | PubTator, text mining | PubMed |
| A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways. | Nat Commun | 2020 | 32532995 | PubTator, text mining | PubMed |
| Immune Cells in the Placental Villi Contribute to Intra-amniotic Inflammation. | Front Immunol | 2020 | 32528468 | PubTator, text mining | PubMed |
| An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma. | Oncotarget | 2020 | 32523648 | PubTator, text mining | PubMed |
| Clinical significance of PI3K/Akt/mTOR signaling in gastric carcinoma. | Int J Clin Exp Pathol | 2020 | 32509071 | PubTator, text mining | PubMed |
| Identification of MicroRNA-Target Gene-Transcription Factor Regulatory Networks in Colorectal Adenoma Using Microarray Expression Data. | Front Genet | 2020 | 32508878 | PubTator, text mining | PubMed |
| Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase. | BMC Cancer | 2020 | 32503472 | PubTator, text mining | PubMed |
| Dynamic Fas signaling network regulates neural stem cell proliferation and memory enhancement. | Sci Adv | 2020 | 32494656 | PubTator, text mining | PubMed |
| STING couples with PI3K to regulate actin reorganization during BCR activation. | Sci Adv | 2020 | 32494627 | PubTator, text mining | PubMed |
| Lysophosphatidic acid reverses Temsirolimus-induced changes in lipid droplets and mitochondrial networks in renal cancer cells. | PLoS One | 2020 | 32492043 | PubTator, text mining | PubMed |
| The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. | Int J Mol Sci | 2020 | 32485838 | PubTator, text mining | PubMed |
| Mechanosensing through YAP controls T cell activation and metabolism. | J Exp Med | 2020 | 32484502 | PubTator, text mining | PubMed |
| Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK-STAT signaling pathways. | Cytometry B Clin Cytom | 2020 | 32479694 | PubTator, text mining | PubMed |
| The Msi1-mTOR pathway drives the pathogenesis of mammary and extramammary Paget's disease. | Cell Res | 2020 | 32457396 | PubTator, text mining | PubMed |
| A systematic molecular and pharmacologic evaluation of AKT inhibitors reveals new insight into their biological activity. | Br J Cancer | 2020 | 32439931 | PubTator, text mining | PubMed |
| Pathway-Specific Genome Editing of PI3K/mTOR Tumor Suppressor Genes Reveals that PTEN Loss Contributes to Cetuximab Resistance in Head and Neck Cancer. | Mol Cancer Ther | 2020 | 32430488 | PubTator, text mining | PubMed |
| Fucosterol Suppresses the Progression of Human Ovarian Cancer by Inducing Mitochondrial Dysfunction and Endoplasmic Reticulum Stress. | Mar Drugs | 2020 | 32429354 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=45